Jiang QH, Chen Y, Wang AX, Luo ZH. Efficacy of combined aluminum magnesium carbonate, esomeprazole and Deanxit in treatment of gastroesophageal reflux disease in young or middle-aged patients with anxiety: An analysis of 60 cases.
Shijie Huaren Xiaohua Zazhi 2013;
21:2331-2334. [DOI:
10.11569/wcjd.v21.i23.2331]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To evaluate the efficacy of combined aluminum magnesium carbonate, esomeprazole and Deanxit in the treatment of gastroesophageal reflux disease in young or middle-aged patients with clinical anxiety.
METHODS: One hundred and eighty young or middle-aged patients were randomly and equally divided into three groups: A, B and C. Group A was treated with aluminum magnesium carbonate, esomeprazole and Deanxit, group B was treated with esomeprazole and Deanxit, and group C was treated with aluminum magnesium carbonate and Deanxi. Clinical remission, extent of repair of the esophageal and gastric mucosa and adverse reactions were compared between the three groups.
RESULTS: After treatment, the number of responders was 58 (96.67%) in group A, 49 (81.67%) in group B, 37 (61.67%) in group C, and the number of patients developing recurrence in the three groups was 1, 8 and 23, respectively. The total response rate, recurrence rate, the extent of repair of the esophageal and gastric mucosa, and the incidence of adverse reactions were better in group A than in groups B and C (all P < 0.05).
CONCLUSION: Combined aluminum magnesium carbonate, esomeprazole and Deanxit are effective in the treatment of gastroesophageal reflux disease with anxiety in terms of symptom relief and repair of the esophageal and gastric mucosa.
Collapse